CIHR Project Grant Awarded for Theranostic Imaging of Prostate Cancer

We are pleased to announce being awarded a CIHR project grant. Our proposal (funded for 4 years; $631,124) is entitled, “Quantitative PSMA Targeted Imaging of Prostate Cancer Patients”. We aim to improve assessment of disease for prostate cancer patients in the context of our ongoing clinical trials involving prostate-specific membrane antigen (PSMA) radioligand therapy (also known as radiopharmaceutical therapy). We will pursue advanced PSMA PET data acquisition (particularly dynamic whole-body imaging), as well as improved image reconstruction and enhancement. Our efforts will also involve automated deep-learning based segmentation of PET images, as well as predictive modeling of prostate cancer using radiomics and machine learning methods.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s